Zobrazeno 1 - 10 of 74 pro vyhledávání: '"Leubitz, A."'
2
Akademický článek
What can family medicine providers learn about concussion non-disclosure from former collegiate athletes?
Autor: Elizabeth A. Beverly, Todd R. Fredricks, Andrew Leubitz, Benjamin R. Oldach, Daniel Kana, Michael D. Grant, Jonathon Whipps, Emily H. Guseman
Publikováno v: BMC Family Practice, Vol 19, Iss 1, Pp 1-11 (2018)
Abstract Background Despite the risks, concussion symptoms often go underreported by athletes, leading to delayed or forgone treatment and increased potential for concussion recurrence. One of the most serious long-term consequences of sports-related
Externí odkaz: https://doaj.org/article/515fb1863c364eaeb1a186b4958a43b1
Zobrazit plný text záznamu
4
Akademický článek
A Randomized, Double‐Blind, Placebo‐Controlled, Multiple Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of ELX‐02 in Healthy Subjects.
Autor: Leubitz, Andi1 (AUTHOR), Vanhoutte, Frederic2 (AUTHOR), Hu, Ming‐yi1 (AUTHOR), Porter, Kaela3 (AUTHOR), Gordon, Efrat1 (AUTHOR), Tencer, Kathleen1 (AUTHOR), Campbell, Kathleen3 (AUTHOR), Banks, Kate1 (AUTHOR) kate.banks@eloxxpharma.com, Haverty, Tom1 (AUTHOR)
Publikováno v: Clinical Pharmacology in Drug Development. Aug2021, Vol. 10 Issue 8, p859-869. 11p.
Zobrazit plný text záznamu
5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
6
Phase 1 Renal Impairment Trial Results Supports Targeted Individualized Dosing of ELX‐02 in Patients With Nephropathic Cystinosis
Autor: Kate Banks, Ming‐yi Hu, Andi Leubitz, Kaela M. Porter, Paul Goodyer, David J. Wyatt, Thomas Haverty
Publikováno v: Journal of Clinical Pharmacology
The aim of this study was to assess the pharmacokinetics (PK) and safety of ELX‐02 in a renally impaired population and apply these findings to the individualized dosing of patients with nephropathic cystinosis. This phase 1 renal impairment (RI; m
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3788bce125abdd0467c7313518e8e65b
https://doi.org/10.1002/jcph.1807
Zobrazit plný text záznamu
7
Akademický článek
Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of ELX‐02, a Potential Treatment for Genetic Disorders Caused by Nonsense Mutations, in Healthy Volunteers.
Autor: Leubitz, Andi1 (AUTHOR) andi@eloxxpharma.com, Frydman‐Marom, Anat1 (AUTHOR), Sharpe, Neal2 (AUTHOR), Duzer, John2 (AUTHOR), Campbell, Kathleen C.M.3 (AUTHOR), Vanhoutte, Frédéric4 (AUTHOR)
Publikováno v: Clinical Pharmacology in Drug Development. Nov2019, Vol. 8 Issue 8, p984-994. 11p.
Zobrazit plný text záznamu
8
Prevalence and Clinical Characteristics of Unintentional Ingestion of Marijuana in Children Younger Than 6 Years in States With and Without Legalized Marijuana Laws
Autor: Andrew, Leubitz, Henry A, Spiller, Heath, Jolliff, Marcel, Casavant
Publikováno v: Pediatric emergency care. 37(12)
The aim of this study was to examine the relationship between state marijuana legalization and the rates of unintentional ingestions of marijuana in children younger than 6 years.This was a retrospective review of all marijuana ingestions in the Nati
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::51c77a4a3cf6f18acede2b56524f4bfa
https://pubmed.ncbi.nlm.nih.gov/34908380
Zobrazit plný text záznamu
9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje